Causal Estimand and Identification
GeoSC reports an unscaled average post-period treated-minus-counterfactual difference. Calling it causal requires more than estimator completion.
For treated set and measured post periods , the target can be written conceptually as
The observed treated outcome supplies . SparseSC estimates the unobserved from eligible donor outcomes.
A causal interpretation needs a stable outcome definition; treatment timing and assignment measured correctly; donors unaffected by treatment; no uncontrolled geography-specific shock aligned with launch; adequate pre-period support for the counterfactual; and an estimand whose geography and period match the business question. These conditions are design arguments, not outputs of the optimiser.
GeoSC’s raw pre-trend comparison is advisory because it compares unweighted group-mean slopes. Synthetic control instead fits a donor combination: treated slopes near two can be matched by mixing donors with slopes zero and four, even when most donors have slopes near zero and the raw mean comparison rejects. This counterexample establishes a mismatch between the raw test and synthetic matchability; it does not establish that the constructed design is causally valid.
Prespecify held-out synthetic-fit checks for model adequacy and keep the causal identification argument separate. The distinction between a weighted comparison, pre-intervention validation and contextual requirements is discussed in Abadie’s methodological review. Neither raw-trend non-rejection nor good synthetic fit proves exchangeability or rules out launch-aligned confounding.
Only GeoSC’s experimental pre-period placebo diagnostic can be explicitly required as an operational gate. Its procedure is unchanged and is not calibrated here; passing it does not establish identification. The interference screen is advisory and has no exposure model. Power addresses detection under a simulated DGP, not identification. State each evidence source separately.